Glaxosmithkline Plc (GSK)

$ 38.66
   
  • Change Today:
    $-0.26
  • 52 Week High: $45.15
  • 52 Week Low: $32.08
  • Currency: US Dollars
  • Shares Issued: 465.72m
  • Volume: 3,667,064
  • Market Cap: $18,005m
  • RiskGrade: 119
  • Beta: 0.22

News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
New Research Shows Many Patients with Persistent... 28-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire the Leading Dry Mouth... 21-Oct-2008 PR Newswire
GSK Notice of Third Quarter 2008 Results Announc... 20-Oct-2008 PR Newswire
LF Elimination Program Treats Over Half Billion ... 07-Oct-2008 PR Newswire
alli(TM) Partners with Breast Cancer Network of ... 22-Sep-2008 PR Newswire
MultiVu Video Feed: NEW BRAIN IMAGING SHOWS THE ... 18-Sep-2008 PR Newswire
GSK and XenoPort Announce Submission of New Drug... 16-Sep-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire
GSK Receives Decision From FDA on Advair(R) 500/... 08-Aug-2007 PR Newswire
GlaxoSmithKline Receives New HHS Order for H5N1 ... 03-Aug-2007 PR Newswire
FDA Issues Second Approvable Letter for Trexima(... 02-Aug-2007 PR Newswire
GlaxoSmithKline Presents Avandia Data To FDA 30-Jul-2007 PR Newswire
FDA Advisory Panel Votes 22 to 1 for Avandia(R) ... 30-Jul-2007 PR Newswire
ChemoCentryx Achieves $5 Million Milestone from ... 24-Jul-2007 PR Newswire
GSK's Cervical Cancer Candidate Vaccine Cervarix... 18-Jul-2007 PR Newswire
Pharmacopeia Advances First Therapeutic Program ... 17-Jul-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency US Dollars
Share Price $ 38.66
Change Today $ -0.26
% Change -0.67 %
52 Week High $45.15
52 Week Low $32.08
Volume 3,667,064
Shares Issued 465.72m
Market Cap $18,005m
Beta 0.22
RiskGrade 119

Trades for 23-May-2025

Time Volume / Share Price
16:00 240,116 @ $38.66
15:59 300 @ $38.69
15:59 100 @ $38.69
15:59 200 @ $38.68
15:59 200 @ $38.68

GSK Key Personnel

CEO Emma Walmsley

Top of Page